Connect with us

National

HISTORIC: Obama signs ‘Don’t Ask’ repeal

Implementation process for open service must follow

Published

on

President Obama signs "Don't Ask" repeal legislation into law (Blade photo by Michael Key).

The long fight to end a 17-year-old law barring open gays from serving in the U.S. military culminated in a significant milestone on Wednesday when President Obama signed into law a bill allowing for repeal of “Don’t Ask, Don’t Tell.”

Prior to the signing, Obama said the legislation will strengthen national security and “uphold the ideals that our fighting men and women risk their lives to defend.”

“No longer will our country be denied the service of thousands of patriotic Americans who are forced to leave the military, regardless of their skills, no matter their bravery or their zeal, no matter their years of exemplary performance because they happen to be gay,” Obama said.

During his remarks, the president also seemed to address those who have concerns about openly gay and lesbian people serving in the U.S. military to allay worries about the change to come.

“Now, with any change, there’s some apprehension,” Obama said. “That’s natural. But as commander-in-chief, I am certain that we can affect this transition in a way that only strengthens our military readiness; that people will look back on this moment and wonder why it was ever a source of controversy in the first place.”

The president signed the legislation in an auditorium at the Department of Interior before an audience of about 500 invitees that included both gay rights supporters and U.S. lawmakers such as Sens. Kirsten Gillibrand (D-N.Y.) and Mark Udall (D-Colo.) as well as gay Reps. Barney Frank (D-Mass.) and Jared Polis (D-Colo.).

Flanking Obama during the signing were gay former service members — Marine Staff Sgt. Eric Alva and Navy Cmdr. Zoe Dunning — as well as lawmakers who worked to pass the legislation, such as Rep. Patrick Murphy (D-Pa.), Sen. Joseph Lieberman (I-Conn.), House Speaker Nancy Pelosi (D-Calif.), Senate Majority Leader Harry Reid (D-Nev.) and Sen. Susan Collins (R-Maine). Chairman of the Joint Chiefs of Staff Adm. Mike Mullen, who has testified before Congress in favor of open service, was also behind the president during the signing.

When he finished signing the bill, Obama declared, “This is done!” and embraced those who were with him on stage as the audience chanted, “U-S-A! U-S-A!”

Prior to the signing, Vice President Joseph Biden told the audience that the legislative repeal of “Don’t Ask, Don’t Tell” marks the fulfillment of the one of the promises to the LGBT community on which he and Obama campaigned in 2008.

“This fulfills an important campaign promise the president and I made, and many here on this stage made, and many of you have fought for, for a long time, in repealing a policy that actually weakens our national security, diminished our ability to have military readiness, and violates the fundamental American principle of fairness and equality — that exact same set of principles that brave gay men and women will now be able to openly defend around the world,” he said.

President Obama signed the bill after the U.S. Senate on Saturday voted to approve the legislation, 65-31. All Democrats who were present voted in favor of the bill; Sen. Joe Manchin (D-W.Va.) didn’t vote. Eight Republicans voted in favor of the legislation: Collins, Sen. Olympia Snowe (R-Maine), Sen. Scott Brown (R-Mass.), Sen. Lisa Murkowski (R-Alaska), Sen. Mark Kirk (R-Ill.), Sen. George Voinovich (R-Ohio), Sen. John Ensign (R-Nev.) and Richard Burr (R-N.C.).

Gay service members discharged under “Don’t Ask, Don’t Tell” who were present in the audience during the signing told the Washington Blade that the occasion overwhelmed them with joyous feelings.

Stacey Vasquez, an Army paralegal who was discharged under “Don’t Ask, Don’t Tell” in 2003, said she was waiting for the moment “for so many years” and she couldn’t be happier.

“I had moments where I had my doubts of whether we were going to make it or not, but we were on the Hill every single day working on this,” Vasquez said. “People were very responsive to our stories about being discharged and why the law was unfair. It was just a matter of getting past the politics.”

Maj. Margaret Witt, an Air Force service member who last month became the first gay person discharged under “Don’t Ask, Don’t Tell” to be reinstated in the military by court order, said the moment of the bill signing will “go down in history.”

“I’m really happy to be here and hopefully carry the spirit of all those who are out there serving today,” Witt said. “It took years — years and years of really hard work and dedication.”

C. Dixon Osburn, who co-founded Servicemembers Legal Defense Network in 1993, said he was feeling “euphoria” following the bill signing and called the moment “the most significant advance in LGBT equality ever.”

“I think when you reduce it down to its essential — the young man and lesbian is not going to have to call SLDN hiding, quivering, wondering if they’re going to jail or if their career is going to be over the next day,” Osburn said. “America is now going to be with them for the first time, and they can serve with honor and integrity. Multiply that by a million, and that’s the significant change that we have today.”

Even though Obama has signed the legislation, repeal won’t take effect immediately. Language in the bill states that open service won’t be implemented until the president, the defense secretary and the chair of the Joint Chiefs certify that the U.S. military is ready for repeal.

There is no set deadline for when this certification must happen. Defense Secretary Robert Gates has said he wants to first institute training to facilitate open service before issuing certification.

After certification, an additional 60-day waiting period for congressional review must pass before “Don’t Ask, Don’t Tell” is officially off the books and gays can serve openly without fear of discharge.

During his remarks, Obama said he’s spoken with the military service chiefs about implementing the change and expects that it will be done quickly.

“I have spoken to every one of the service chiefs and they are all committed to implementing this change swiftly and efficiently,” Obama said. “We are not going to be dragging our feet to get this done.”

On Wednesday, White House Press Secretary Robert Gibbs said during a news conference that the president believes implementation of repeal of “Don’t Ask, Don’t Tell” would be “a matter of months.”

Aubrey Sarvis, SLDN’s executive director, has been pushing for certification to happen in a matter of weeks so that open service can begin in the first quarter of next year. He added that his organization will be “looking closely” at the new regulations that the Pentagon issues on gays in the military following certification.

“The regulations will be critical,” he said. “We’ll be working closely with [the Defense Department] on that and at SLDN, I think, our key role in 2011 — and probably the following year — will be oversight. Oversight of how the regulations are issued [and] oversight on how they are administrated.”

Even though the president has signed the bill into law, opponents of open service in the military continue to pursue avenues to block “Don’t Ask, Don’t Tell” repeal before it’s implemented.

On Tuesday, Senate Minority Leader Mitch McConnell tried to attach an amendment to the fiscal year 2011 defense authorization bill pending before the Senate to expand the certification responsibilities to include the military service chiefs. Since many of the chiefs have expressed opposition to open service at this time, such a measure could have delayed implementation indefinitely.

However, the amendment was blocked on Tuesday after Sen. Joseph Lieberman (I-Conn.), the sponsor of repeal legislation in the Senate, objected to the measure.

Sarvis said there is “room for mischief” as long as certification is outstanding because opponents of “Don’t Ask, Don’t Tell” repeal could continue to propose similar amendments that would meddle with the process.

“No one should be mistaken that opponents will try to undo this before it gets off the ground,” Sarvis said.

Legislative repeal of “Don’t Ask, Don’t Tell” was one of President Obama’s major promises to the LGBT community, but a number of gay rights supporters say they are expecting more from him during his presidency.

John Aravosis, the gay editor of Americablog, said repeal of “Don’t Ask, Don’t Tell” is but one item crossed off the list and other promises are still outstanding, such as repeal of the Defense of Marriage Act and passage of the Employment Non-Discrimination Act.

“By now, I was expecting ENDA passed and [‘Don’t Ask, Don’t Tell’] repealed, with a promise to get to DOMA soon,” Aravosis said.” We still have to wait until next year to see whether [‘Don’t Ask, Don’t Tell’] is truly and fully repealed, and forget about ENDA and DOMA for years to come. I’m glad the [‘Don’t Ask, Don’t Tell’] legislation passed this weekend, and I’m glad the president finally got engaged. But we are at best getting one of the three big civil rights promises the president made to us, and that’s it for a long time coming.”

Dan Choi, an Iraq war veteran discharged under “Don’t Ask, Don’t Tell” who has chained himself to the White House in protest over the law, also said he wants more from Obama.

Asked by the Blade what his feelings were during the signing, Choi replied, “I want to get married — that’s my feeling,” referencing Obama’s opposition to same-sex marriage.

“I think today is a day that we can applaud him for signing it, and I recognize that it wouldn’t have been signed by his opponents, and I cheer for him and our hearts are with him,” Choi said. “This morning was historic, but this afternoon we start planning on how to hold him accountable for all the other promises and all the other things that we deserve as citizens.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular